nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP3A7—Ifosfamide—testicular cancer	0.109	0.164	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.109	0.164	CbGbCtD
Zalcitabine—SLC22A7—Methotrexate—testicular cancer	0.0886	0.134	CbGbCtD
Zalcitabine—CYP3A5—Ifosfamide—testicular cancer	0.0817	0.123	CbGbCtD
Zalcitabine—CYP2C9—Ifosfamide—testicular cancer	0.0548	0.0826	CbGbCtD
Zalcitabine—CYP3A5—Etoposide—testicular cancer	0.039	0.0588	CbGbCtD
Zalcitabine—SLC22A6—Methotrexate—testicular cancer	0.0377	0.0568	CbGbCtD
Zalcitabine—CYP3A4—Ifosfamide—testicular cancer	0.0318	0.048	CbGbCtD
Zalcitabine—CYP2C9—Cisplatin—testicular cancer	0.0266	0.0402	CbGbCtD
Zalcitabine—CYP2D6—Vinblastine—testicular cancer	0.0266	0.0401	CbGbCtD
Zalcitabine—CYP3A4—Vinblastine—testicular cancer	0.0169	0.0255	CbGbCtD
Zalcitabine—CYP2D6—Doxorubicin—testicular cancer	0.0163	0.0246	CbGbCtD
Zalcitabine—CYP3A4—Etoposide—testicular cancer	0.0152	0.0229	CbGbCtD
Zalcitabine—CYP3A4—Doxorubicin—testicular cancer	0.0104	0.0156	CbGbCtD
Zalcitabine—DCK—Doxorubicin—Epirubicin—testicular cancer	0.0021	0.519	CbGdCrCtD
Zalcitabine—DCK—Epirubicin—Doxorubicin—testicular cancer	0.00194	0.481	CbGdCrCtD
Zalcitabine—Decreased appetite—Cisplatin—testicular cancer	0.000224	0.000674	CcSEcCtD
Zalcitabine—Diarrhoea—Dactinomycin—testicular cancer	0.000223	0.000672	CcSEcCtD
Zalcitabine—Nasopharyngitis—Doxorubicin—testicular cancer	0.000223	0.000671	CcSEcCtD
Zalcitabine—Vomiting—Bleomycin—testicular cancer	0.000223	0.000669	CcSEcCtD
Zalcitabine—Depression—Methotrexate—testicular cancer	0.000221	0.000665	CcSEcCtD
Zalcitabine—Rash—Bleomycin—testicular cancer	0.000221	0.000664	CcSEcCtD
Zalcitabine—Gastritis—Doxorubicin—testicular cancer	0.000221	0.000664	CcSEcCtD
Zalcitabine—Pain—Cisplatin—testicular cancer	0.000221	0.000663	CcSEcCtD
Zalcitabine—Dermatitis—Bleomycin—testicular cancer	0.000221	0.000663	CcSEcCtD
Zalcitabine—Hypersensitivity—Ifosfamide—testicular cancer	0.000221	0.000663	CcSEcCtD
Zalcitabine—Muscular weakness—Doxorubicin—testicular cancer	0.00022	0.000661	CcSEcCtD
Zalcitabine—Neutropenia—Epirubicin—testicular cancer	0.000218	0.000655	CcSEcCtD
Zalcitabine—Dysuria—Epirubicin—testicular cancer	0.000218	0.000655	CcSEcCtD
Zalcitabine—Abdominal distension—Doxorubicin—testicular cancer	0.000217	0.000652	CcSEcCtD
Zalcitabine—Dysphagia—Doxorubicin—testicular cancer	0.000216	0.000648	CcSEcCtD
Zalcitabine—Pollakiuria—Epirubicin—testicular cancer	0.000215	0.000647	CcSEcCtD
Zalcitabine—Asthenia—Ifosfamide—testicular cancer	0.000215	0.000645	CcSEcCtD
Zalcitabine—Eosinophilia—Doxorubicin—testicular cancer	0.000213	0.000642	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000213	0.000639	CcSEcCtD
Zalcitabine—Feeling abnormal—Cisplatin—testicular cancer	0.000213	0.000639	CcSEcCtD
Zalcitabine—Pruritus—Ifosfamide—testicular cancer	0.000212	0.000636	CcSEcCtD
Zalcitabine—Pancreatitis—Doxorubicin—testicular cancer	0.000211	0.000635	CcSEcCtD
Zalcitabine—Weight decreased—Epirubicin—testicular cancer	0.000211	0.000634	CcSEcCtD
Zalcitabine—Dyspnoea—Etoposide—testicular cancer	0.000211	0.000633	CcSEcCtD
Zalcitabine—Hyperglycaemia—Epirubicin—testicular cancer	0.00021	0.000632	CcSEcCtD
Zalcitabine—Somnolence—Etoposide—testicular cancer	0.00021	0.000632	CcSEcCtD
Zalcitabine—Epistaxis—Methotrexate—testicular cancer	0.000209	0.000629	CcSEcCtD
Zalcitabine—Vomiting—Dactinomycin—testicular cancer	0.000208	0.000624	CcSEcCtD
Zalcitabine—Rash—Dactinomycin—testicular cancer	0.000206	0.000619	CcSEcCtD
Zalcitabine—Decreased appetite—Etoposide—testicular cancer	0.000205	0.000618	CcSEcCtD
Zalcitabine—Diarrhoea—Ifosfamide—testicular cancer	0.000205	0.000616	CcSEcCtD
Zalcitabine—Body temperature increased—Cisplatin—testicular cancer	0.000204	0.000613	CcSEcCtD
Zalcitabine—Fatigue—Etoposide—testicular cancer	0.000204	0.000613	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000204	0.000612	CcSEcCtD
Zalcitabine—Jaundice—Epirubicin—testicular cancer	0.000203	0.000609	CcSEcCtD
Zalcitabine—Pain—Etoposide—testicular cancer	0.000202	0.000608	CcSEcCtD
Zalcitabine—Dysuria—Doxorubicin—testicular cancer	0.000202	0.000606	CcSEcCtD
Zalcitabine—Neutropenia—Doxorubicin—testicular cancer	0.000202	0.000606	CcSEcCtD
Zalcitabine—Hepatitis—Methotrexate—testicular cancer	0.000199	0.000599	CcSEcCtD
Zalcitabine—Pollakiuria—Doxorubicin—testicular cancer	0.000199	0.000599	CcSEcCtD
Zalcitabine—Dizziness—Ifosfamide—testicular cancer	0.000198	0.000595	CcSEcCtD
Zalcitabine—Pharyngitis—Methotrexate—testicular cancer	0.000198	0.000595	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000197	0.000592	CcSEcCtD
Zalcitabine—Epistaxis—Epirubicin—testicular cancer	0.000196	0.000589	CcSEcCtD
Zalcitabine—Weight decreased—Doxorubicin—testicular cancer	0.000195	0.000586	CcSEcCtD
Zalcitabine—Sinusitis—Epirubicin—testicular cancer	0.000195	0.000586	CcSEcCtD
Zalcitabine—Feeling abnormal—Etoposide—testicular cancer	0.000195	0.000586	CcSEcCtD
Zalcitabine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000194	0.000585	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Etoposide—testicular cancer	0.000193	0.000581	CcSEcCtD
Zalcitabine—Visual impairment—Methotrexate—testicular cancer	0.000192	0.000577	CcSEcCtD
Zalcitabine—Vomiting—Ifosfamide—testicular cancer	0.00019	0.000572	CcSEcCtD
Zalcitabine—Hypersensitivity—Cisplatin—testicular cancer	0.00019	0.000571	CcSEcCtD
Zalcitabine—Rash—Ifosfamide—testicular cancer	0.000189	0.000567	CcSEcCtD
Zalcitabine—Dermatitis—Ifosfamide—testicular cancer	0.000189	0.000567	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000188	0.000566	CcSEcCtD
Zalcitabine—Urticaria—Etoposide—testicular cancer	0.000188	0.000564	CcSEcCtD
Zalcitabine—Jaundice—Doxorubicin—testicular cancer	0.000187	0.000563	CcSEcCtD
Zalcitabine—Rhinitis—Epirubicin—testicular cancer	0.000187	0.000562	CcSEcCtD
Zalcitabine—Body temperature increased—Etoposide—testicular cancer	0.000187	0.000562	CcSEcCtD
Zalcitabine—Abdominal pain—Etoposide—testicular cancer	0.000187	0.000562	CcSEcCtD
Zalcitabine—Hepatitis—Epirubicin—testicular cancer	0.000187	0.000561	CcSEcCtD
Zalcitabine—Eye disorder—Methotrexate—testicular cancer	0.000186	0.00056	CcSEcCtD
Zalcitabine—Tinnitus—Methotrexate—testicular cancer	0.000186	0.000559	CcSEcCtD
Zalcitabine—Asthenia—Cisplatin—testicular cancer	0.000185	0.000556	CcSEcCtD
Zalcitabine—Pharyngitis—Epirubicin—testicular cancer	0.000185	0.000556	CcSEcCtD
Zalcitabine—Epistaxis—Doxorubicin—testicular cancer	0.000181	0.000545	CcSEcCtD
Zalcitabine—Sinusitis—Doxorubicin—testicular cancer	0.00018	0.000542	CcSEcCtD
Zalcitabine—Visual impairment—Epirubicin—testicular cancer	0.00018	0.00054	CcSEcCtD
Zalcitabine—Chills—Methotrexate—testicular cancer	0.000179	0.000538	CcSEcCtD
Zalcitabine—Diarrhoea—Cisplatin—testicular cancer	0.000177	0.000531	CcSEcCtD
Zalcitabine—Alopecia—Methotrexate—testicular cancer	0.000176	0.000529	CcSEcCtD
Zalcitabine—Eye disorder—Epirubicin—testicular cancer	0.000174	0.000524	CcSEcCtD
Zalcitabine—Hypersensitivity—Etoposide—testicular cancer	0.000174	0.000524	CcSEcCtD
Zalcitabine—Tinnitus—Epirubicin—testicular cancer	0.000174	0.000523	CcSEcCtD
Zalcitabine—Flushing—Epirubicin—testicular cancer	0.000173	0.00052	CcSEcCtD
Zalcitabine—Rhinitis—Doxorubicin—testicular cancer	0.000173	0.00052	CcSEcCtD
Zalcitabine—Hepatitis—Doxorubicin—testicular cancer	0.000173	0.000519	CcSEcCtD
Zalcitabine—Pharyngitis—Doxorubicin—testicular cancer	0.000171	0.000515	CcSEcCtD
Zalcitabine—Dysgeusia—Methotrexate—testicular cancer	0.00017	0.000511	CcSEcCtD
Zalcitabine—Asthenia—Etoposide—testicular cancer	0.00017	0.00051	CcSEcCtD
Zalcitabine—Back pain—Methotrexate—testicular cancer	0.000168	0.000504	CcSEcCtD
Zalcitabine—Chills—Epirubicin—testicular cancer	0.000167	0.000503	CcSEcCtD
Zalcitabine—Pruritus—Etoposide—testicular cancer	0.000167	0.000503	CcSEcCtD
Zalcitabine—Arrhythmia—Epirubicin—testicular cancer	0.000167	0.000501	CcSEcCtD
Zalcitabine—Visual impairment—Doxorubicin—testicular cancer	0.000166	0.0005	CcSEcCtD
Zalcitabine—Alopecia—Epirubicin—testicular cancer	0.000165	0.000495	CcSEcCtD
Zalcitabine—Vomiting—Cisplatin—testicular cancer	0.000164	0.000493	CcSEcCtD
Zalcitabine—Vision blurred—Methotrexate—testicular cancer	0.000164	0.000491	CcSEcCtD
Zalcitabine—Rash—Cisplatin—testicular cancer	0.000163	0.000489	CcSEcCtD
Zalcitabine—Dermatitis—Cisplatin—testicular cancer	0.000163	0.000489	CcSEcCtD
Zalcitabine—Diarrhoea—Etoposide—testicular cancer	0.000162	0.000486	CcSEcCtD
Zalcitabine—Eye disorder—Doxorubicin—testicular cancer	0.000161	0.000485	CcSEcCtD
Zalcitabine—Ill-defined disorder—Methotrexate—testicular cancer	0.000161	0.000484	CcSEcCtD
Zalcitabine—Tinnitus—Doxorubicin—testicular cancer	0.000161	0.000484	CcSEcCtD
Zalcitabine—Anaemia—Methotrexate—testicular cancer	0.00016	0.000482	CcSEcCtD
Zalcitabine—Flushing—Doxorubicin—testicular cancer	0.00016	0.000481	CcSEcCtD
Zalcitabine—Flatulence—Epirubicin—testicular cancer	0.00016	0.000481	CcSEcCtD
Zalcitabine—Tension—Epirubicin—testicular cancer	0.000159	0.000479	CcSEcCtD
Zalcitabine—Dysgeusia—Epirubicin—testicular cancer	0.000159	0.000478	CcSEcCtD
Zalcitabine—Nervousness—Epirubicin—testicular cancer	0.000158	0.000474	CcSEcCtD
Zalcitabine—Back pain—Epirubicin—testicular cancer	0.000157	0.000472	CcSEcCtD
Zalcitabine—Malaise—Methotrexate—testicular cancer	0.000156	0.00047	CcSEcCtD
Zalcitabine—Dizziness—Etoposide—testicular cancer	0.000156	0.00047	CcSEcCtD
Zalcitabine—Muscle spasms—Epirubicin—testicular cancer	0.000156	0.000469	CcSEcCtD
Zalcitabine—Vertigo—Methotrexate—testicular cancer	0.000156	0.000469	CcSEcCtD
Zalcitabine—Leukopenia—Methotrexate—testicular cancer	0.000155	0.000467	CcSEcCtD
Zalcitabine—Chills—Doxorubicin—testicular cancer	0.000155	0.000465	CcSEcCtD
Zalcitabine—Arrhythmia—Doxorubicin—testicular cancer	0.000154	0.000463	CcSEcCtD
Zalcitabine—Vision blurred—Epirubicin—testicular cancer	0.000153	0.00046	CcSEcCtD
Zalcitabine—Alopecia—Doxorubicin—testicular cancer	0.000152	0.000458	CcSEcCtD
Zalcitabine—Cough—Methotrexate—testicular cancer	0.000151	0.000455	CcSEcCtD
Zalcitabine—Ill-defined disorder—Epirubicin—testicular cancer	0.000151	0.000453	CcSEcCtD
Zalcitabine—Convulsion—Methotrexate—testicular cancer	0.00015	0.000452	CcSEcCtD
Zalcitabine—Vomiting—Etoposide—testicular cancer	0.00015	0.000452	CcSEcCtD
Zalcitabine—Anaemia—Epirubicin—testicular cancer	0.00015	0.000451	CcSEcCtD
Zalcitabine—Agitation—Epirubicin—testicular cancer	0.000149	0.000448	CcSEcCtD
Zalcitabine—Rash—Etoposide—testicular cancer	0.000149	0.000448	CcSEcCtD
Zalcitabine—Dermatitis—Etoposide—testicular cancer	0.000149	0.000448	CcSEcCtD
Zalcitabine—Headache—Etoposide—testicular cancer	0.000148	0.000445	CcSEcCtD
Zalcitabine—Flatulence—Doxorubicin—testicular cancer	0.000148	0.000445	CcSEcCtD
Zalcitabine—Arthralgia—Methotrexate—testicular cancer	0.000148	0.000444	CcSEcCtD
Zalcitabine—Myalgia—Methotrexate—testicular cancer	0.000148	0.000444	CcSEcCtD
Zalcitabine—Tension—Doxorubicin—testicular cancer	0.000147	0.000443	CcSEcCtD
Zalcitabine—Dysgeusia—Doxorubicin—testicular cancer	0.000147	0.000442	CcSEcCtD
Zalcitabine—Malaise—Epirubicin—testicular cancer	0.000146	0.00044	CcSEcCtD
Zalcitabine—Discomfort—Methotrexate—testicular cancer	0.000146	0.000439	CcSEcCtD
Zalcitabine—Nervousness—Doxorubicin—testicular cancer	0.000146	0.000439	CcSEcCtD
Zalcitabine—Vertigo—Epirubicin—testicular cancer	0.000146	0.000438	CcSEcCtD
Zalcitabine—Syncope—Epirubicin—testicular cancer	0.000146	0.000438	CcSEcCtD
Zalcitabine—Leukopenia—Epirubicin—testicular cancer	0.000145	0.000437	CcSEcCtD
Zalcitabine—Back pain—Doxorubicin—testicular cancer	0.000145	0.000437	CcSEcCtD
Zalcitabine—Muscle spasms—Doxorubicin—testicular cancer	0.000144	0.000434	CcSEcCtD
Zalcitabine—Palpitations—Epirubicin—testicular cancer	0.000143	0.000431	CcSEcCtD
Zalcitabine—Confusional state—Methotrexate—testicular cancer	0.000143	0.000429	CcSEcCtD
Zalcitabine—Loss of consciousness—Epirubicin—testicular cancer	0.000143	0.000429	CcSEcCtD
Zalcitabine—Cough—Epirubicin—testicular cancer	0.000142	0.000426	CcSEcCtD
Zalcitabine—Vision blurred—Doxorubicin—testicular cancer	0.000142	0.000426	CcSEcCtD
Zalcitabine—Convulsion—Epirubicin—testicular cancer	0.000141	0.000423	CcSEcCtD
Zalcitabine—Infection—Methotrexate—testicular cancer	0.000141	0.000423	CcSEcCtD
Zalcitabine—Hypertension—Epirubicin—testicular cancer	0.00014	0.000421	CcSEcCtD
Zalcitabine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000139	0.000419	CcSEcCtD
Zalcitabine—Anaemia—Doxorubicin—testicular cancer	0.000139	0.000417	CcSEcCtD
Zalcitabine—Thrombocytopenia—Methotrexate—testicular cancer	0.000139	0.000417	CcSEcCtD
Zalcitabine—Arthralgia—Epirubicin—testicular cancer	0.000138	0.000415	CcSEcCtD
Zalcitabine—Myalgia—Epirubicin—testicular cancer	0.000138	0.000415	CcSEcCtD
Zalcitabine—Agitation—Doxorubicin—testicular cancer	0.000138	0.000415	CcSEcCtD
Zalcitabine—Anxiety—Epirubicin—testicular cancer	0.000138	0.000414	CcSEcCtD
Zalcitabine—Skin disorder—Methotrexate—testicular cancer	0.000138	0.000413	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methotrexate—testicular cancer	0.000137	0.000411	CcSEcCtD
Zalcitabine—Discomfort—Epirubicin—testicular cancer	0.000137	0.000411	CcSEcCtD
Zalcitabine—Malaise—Doxorubicin—testicular cancer	0.000135	0.000407	CcSEcCtD
Zalcitabine—Dry mouth—Epirubicin—testicular cancer	0.000135	0.000406	CcSEcCtD
Zalcitabine—Vertigo—Doxorubicin—testicular cancer	0.000135	0.000406	CcSEcCtD
Zalcitabine—Anorexia—Methotrexate—testicular cancer	0.000135	0.000406	CcSEcCtD
Zalcitabine—Syncope—Doxorubicin—testicular cancer	0.000135	0.000405	CcSEcCtD
Zalcitabine—Leukopenia—Doxorubicin—testicular cancer	0.000134	0.000404	CcSEcCtD
Zalcitabine—Confusional state—Epirubicin—testicular cancer	0.000134	0.000402	CcSEcCtD
Zalcitabine—Palpitations—Doxorubicin—testicular cancer	0.000133	0.000399	CcSEcCtD
Zalcitabine—Oedema—Epirubicin—testicular cancer	0.000133	0.000398	CcSEcCtD
Zalcitabine—Loss of consciousness—Doxorubicin—testicular cancer	0.000132	0.000397	CcSEcCtD
Zalcitabine—Infection—Epirubicin—testicular cancer	0.000132	0.000396	CcSEcCtD
Zalcitabine—Cough—Doxorubicin—testicular cancer	0.000131	0.000394	CcSEcCtD
Zalcitabine—Shock—Epirubicin—testicular cancer	0.00013	0.000392	CcSEcCtD
Zalcitabine—Convulsion—Doxorubicin—testicular cancer	0.00013	0.000391	CcSEcCtD
Zalcitabine—Thrombocytopenia—Epirubicin—testicular cancer	0.00013	0.00039	CcSEcCtD
Zalcitabine—Hypertension—Doxorubicin—testicular cancer	0.00013	0.00039	CcSEcCtD
Zalcitabine—Tachycardia—Epirubicin—testicular cancer	0.000129	0.000389	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000129	0.000388	CcSEcCtD
Zalcitabine—Skin disorder—Epirubicin—testicular cancer	0.000129	0.000387	CcSEcCtD
Zalcitabine—Hyperhidrosis—Epirubicin—testicular cancer	0.000128	0.000385	CcSEcCtD
Zalcitabine—Insomnia—Methotrexate—testicular cancer	0.000128	0.000385	CcSEcCtD
Zalcitabine—Arthralgia—Doxorubicin—testicular cancer	0.000128	0.000384	CcSEcCtD
Zalcitabine—Myalgia—Doxorubicin—testicular cancer	0.000128	0.000384	CcSEcCtD
Zalcitabine—Anxiety—Doxorubicin—testicular cancer	0.000127	0.000383	CcSEcCtD
Zalcitabine—Discomfort—Doxorubicin—testicular cancer	0.000126	0.00038	CcSEcCtD
Zalcitabine—Anorexia—Epirubicin—testicular cancer	0.000126	0.00038	CcSEcCtD
Zalcitabine—Dyspnoea—Methotrexate—testicular cancer	0.000126	0.000379	CcSEcCtD
Zalcitabine—Somnolence—Methotrexate—testicular cancer	0.000126	0.000378	CcSEcCtD
Zalcitabine—Dry mouth—Doxorubicin—testicular cancer	0.000125	0.000376	CcSEcCtD
Zalcitabine—Dyspepsia—Methotrexate—testicular cancer	0.000125	0.000375	CcSEcCtD
Zalcitabine—Confusional state—Doxorubicin—testicular cancer	0.000124	0.000372	CcSEcCtD
Zalcitabine—Decreased appetite—Methotrexate—testicular cancer	0.000123	0.00037	CcSEcCtD
Zalcitabine—Oedema—Doxorubicin—testicular cancer	0.000123	0.000369	CcSEcCtD
Zalcitabine—Fatigue—Methotrexate—testicular cancer	0.000122	0.000367	CcSEcCtD
Zalcitabine—Infection—Doxorubicin—testicular cancer	0.000122	0.000366	CcSEcCtD
Zalcitabine—Pain—Methotrexate—testicular cancer	0.000121	0.000364	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000121	0.000363	CcSEcCtD
Zalcitabine—Shock—Doxorubicin—testicular cancer	0.000121	0.000363	CcSEcCtD
Zalcitabine—Thrombocytopenia—Doxorubicin—testicular cancer	0.00012	0.000361	CcSEcCtD
Zalcitabine—Insomnia—Epirubicin—testicular cancer	0.00012	0.00036	CcSEcCtD
Zalcitabine—Tachycardia—Doxorubicin—testicular cancer	0.00012	0.00036	CcSEcCtD
Zalcitabine—Skin disorder—Doxorubicin—testicular cancer	0.000119	0.000358	CcSEcCtD
Zalcitabine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000119	0.000356	CcSEcCtD
Zalcitabine—Dyspnoea—Epirubicin—testicular cancer	0.000118	0.000355	CcSEcCtD
Zalcitabine—Somnolence—Epirubicin—testicular cancer	0.000118	0.000354	CcSEcCtD
Zalcitabine—Anorexia—Doxorubicin—testicular cancer	0.000117	0.000351	CcSEcCtD
Zalcitabine—Feeling abnormal—Methotrexate—testicular cancer	0.000117	0.000351	CcSEcCtD
Zalcitabine—Dyspepsia—Epirubicin—testicular cancer	0.000117	0.000351	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000116	0.000348	CcSEcCtD
Zalcitabine—Decreased appetite—Epirubicin—testicular cancer	0.000115	0.000346	CcSEcCtD
Zalcitabine—Fatigue—Epirubicin—testicular cancer	0.000114	0.000343	CcSEcCtD
Zalcitabine—Pain—Epirubicin—testicular cancer	0.000113	0.000341	CcSEcCtD
Zalcitabine—Urticaria—Methotrexate—testicular cancer	0.000112	0.000338	CcSEcCtD
Zalcitabine—Body temperature increased—Methotrexate—testicular cancer	0.000112	0.000336	CcSEcCtD
Zalcitabine—Abdominal pain—Methotrexate—testicular cancer	0.000112	0.000336	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000112	0.000336	CcSEcCtD
Zalcitabine—Insomnia—Doxorubicin—testicular cancer	0.000111	0.000333	CcSEcCtD
Zalcitabine—Dyspnoea—Doxorubicin—testicular cancer	0.000109	0.000329	CcSEcCtD
Zalcitabine—Feeling abnormal—Epirubicin—testicular cancer	0.000109	0.000328	CcSEcCtD
Zalcitabine—Somnolence—Doxorubicin—testicular cancer	0.000109	0.000328	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000108	0.000326	CcSEcCtD
Zalcitabine—Dyspepsia—Doxorubicin—testicular cancer	0.000108	0.000324	CcSEcCtD
Zalcitabine—Decreased appetite—Doxorubicin—testicular cancer	0.000107	0.00032	CcSEcCtD
Zalcitabine—Fatigue—Doxorubicin—testicular cancer	0.000106	0.000318	CcSEcCtD
Zalcitabine—Urticaria—Epirubicin—testicular cancer	0.000105	0.000316	CcSEcCtD
Zalcitabine—Pain—Doxorubicin—testicular cancer	0.000105	0.000315	CcSEcCtD
Zalcitabine—Body temperature increased—Epirubicin—testicular cancer	0.000105	0.000315	CcSEcCtD
Zalcitabine—Abdominal pain—Epirubicin—testicular cancer	0.000105	0.000315	CcSEcCtD
Zalcitabine—Hypersensitivity—Methotrexate—testicular cancer	0.000104	0.000314	CcSEcCtD
Zalcitabine—Asthenia—Methotrexate—testicular cancer	0.000102	0.000305	CcSEcCtD
Zalcitabine—Feeling abnormal—Doxorubicin—testicular cancer	0.000101	0.000304	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.0001	0.000301	CcSEcCtD
Zalcitabine—Pruritus—Methotrexate—testicular cancer	0.0001	0.000301	CcSEcCtD
Zalcitabine—Hypersensitivity—Epirubicin—testicular cancer	9.76e-05	0.000293	CcSEcCtD
Zalcitabine—Urticaria—Doxorubicin—testicular cancer	9.74e-05	0.000293	CcSEcCtD
Zalcitabine—Abdominal pain—Doxorubicin—testicular cancer	9.69e-05	0.000291	CcSEcCtD
Zalcitabine—Body temperature increased—Doxorubicin—testicular cancer	9.69e-05	0.000291	CcSEcCtD
Zalcitabine—Diarrhoea—Methotrexate—testicular cancer	9.69e-05	0.000291	CcSEcCtD
Zalcitabine—Asthenia—Epirubicin—testicular cancer	9.51e-05	0.000286	CcSEcCtD
Zalcitabine—Pruritus—Epirubicin—testicular cancer	9.37e-05	0.000282	CcSEcCtD
Zalcitabine—Dizziness—Methotrexate—testicular cancer	9.36e-05	0.000281	CcSEcCtD
Zalcitabine—Diarrhoea—Epirubicin—testicular cancer	9.07e-05	0.000273	CcSEcCtD
Zalcitabine—Hypersensitivity—Doxorubicin—testicular cancer	9.03e-05	0.000272	CcSEcCtD
Zalcitabine—Vomiting—Methotrexate—testicular cancer	9e-05	0.000271	CcSEcCtD
Zalcitabine—Rash—Methotrexate—testicular cancer	8.93e-05	0.000268	CcSEcCtD
Zalcitabine—Dermatitis—Methotrexate—testicular cancer	8.92e-05	0.000268	CcSEcCtD
Zalcitabine—Headache—Methotrexate—testicular cancer	8.87e-05	0.000267	CcSEcCtD
Zalcitabine—Asthenia—Doxorubicin—testicular cancer	8.8e-05	0.000264	CcSEcCtD
Zalcitabine—Dizziness—Epirubicin—testicular cancer	8.76e-05	0.000263	CcSEcCtD
Zalcitabine—Pruritus—Doxorubicin—testicular cancer	8.67e-05	0.000261	CcSEcCtD
Zalcitabine—Vomiting—Epirubicin—testicular cancer	8.42e-05	0.000253	CcSEcCtD
Zalcitabine—Diarrhoea—Doxorubicin—testicular cancer	8.39e-05	0.000252	CcSEcCtD
Zalcitabine—Rash—Epirubicin—testicular cancer	8.35e-05	0.000251	CcSEcCtD
Zalcitabine—Dermatitis—Epirubicin—testicular cancer	8.35e-05	0.000251	CcSEcCtD
Zalcitabine—Headache—Epirubicin—testicular cancer	8.3e-05	0.00025	CcSEcCtD
Zalcitabine—Dizziness—Doxorubicin—testicular cancer	8.11e-05	0.000244	CcSEcCtD
Zalcitabine—Vomiting—Doxorubicin—testicular cancer	7.8e-05	0.000234	CcSEcCtD
Zalcitabine—Rash—Doxorubicin—testicular cancer	7.73e-05	0.000232	CcSEcCtD
Zalcitabine—Dermatitis—Doxorubicin—testicular cancer	7.72e-05	0.000232	CcSEcCtD
Zalcitabine—Headache—Doxorubicin—testicular cancer	7.68e-05	0.000231	CcSEcCtD
